<ul>
<li>PFTs included spirometry, lung volumes, and DLCO. DLCO, diffusion capacity for carbon monoxide; HRCT chest, high-resolution computed tomography of the chest; IIM, idiopathic inflammatory myopathies; ILD, interstitial lung disease; MCTD, mixed connective tissue disease; PFT, pulmonary function test; RA, rheumatoid arthritis; SARD, systemic autoimmune rheumatic disease; SjD, Sj√∂gren disease; SSc, systemic sclerosis; 6MWD, 6-minute walk test distance.</li>
</ul>

<h1>Table 4. Summary of Voting Panel decisions, PICO questions, and evidence for screening of people with SARDs at risk of developing ILD that led to recommendations*</h1>